Analyze Diet
Muscle & nerve2004; 30(3); 356-365; doi: 10.1002/mus.20084

Association of a mutation in the ryanodine receptor 1 gene with equine malignant hyperthermia.

Abstract: Equine malignant hyperthermia MH has been suspected but never genetically confirmed. In this study, we investigated whether mutations in a candidate gene, RyR1, were associated with MH in two clinically affected horses. RyR1 gene sequences revealed polymorphisms in exons 15, 17, and 46 in WTRyR1 and MHRyR1 horses with one derived amino acid change in MHRyR1 exon 46, R2454G. The MHRyR1 horses were genetically heterozygous for this mutation, but presented an MH phenotype with halothane challenge. Skeletal sarcoplasmic reticulum from a R2454G heterozygote collected during a fulminant MH episode showed significantly higher affinity and density of [3H]ryanodine-binding sites compared to WTRyR1, but no differences in Ca2+, Mg2+, and caffeine modulation. In conclusion, an autosomal missense mutation in RyR1 is associated with MH in the horse, providing a screening test for susceptible individuals. [3H]ryanodine-binding analysis suggests that long-lasting changes in RyR1 conformation persists in vitro after the triggering event.
Publication Date: 2004-08-20 PubMed ID: 15318347DOI: 10.1002/mus.20084Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article
  • Research Support
  • U.S. Gov't
  • P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research aimed to investigate the association of a mutation in the Ryanodine receptor 1 (RyR1) gene with a condition in horses known as Malignant Hyperthermia (MH). The study confirms, through genetic testing, that a specific mutation in the RyR1 gene is related to MH in horses, providing a potential method of screening susceptible individuals.

Mutation in RyR1 Gene and Malignant Hyperthermia

  • The research was primarily conducted to investigate the association of a mutation of the Ryanodine receptor 1 gene (RyR1), known for encoding a protein essential for muscle contraction in mammals, with Malignant Hyperthermia (MH) in horses.
  • MH is a potentially fatal reaction to certain types of anesthesia, and its influence with RyR1 gene mutations had not been genetically proven until this study.

Investigation and Findings

  • Two horses clinically affected by MH were examined for this study. The experimentation, involving gene sequencing, unearthed variations in sequences of exon 15, 17, and 46 of the RyR1 gene in both horses.
  • A crucial discovery, and the primary focal point of the research, was a mutation in exon 46 (R2454G). This mutation was found in heterozygous states within the MHRyR1 horses.
  • Further corroborating this implication of the RyR1 mutation, horses carrying the R2454G mutation presented an MH phenotype when put through a halothane challenge, a specific diagnostic test for MH.

Skeletal Sarcoplasmic Retriculum and [3H]ryanodine-binding Analysis

  • The study also involved analysis of the skeletal sarcoplasmic reticulum. The results indicated a significantly increased affinity and density of [3H]ryanodine-binding sites in a horse carrying the R2454G mutation during an active MH episode, compared to the horse without the mutation.
  • However, no noticeable differences were found in the modulation of calcium (Ca2+), magnesium (Mg2+), and caffeine.
  • These results suggest the occurrence of persistent, long-lasting changes in RyR1 conformation in vitro, even after the triggering event has passed.

Closer Look at MH and RyR1 Relationship

  • The research concludes that an autosomal missense mutation in the RyR1 gene is indeed associated with MH in horses, which is a fundamental advancement in the understanding of MH and its triggering factors in horses.
  • This finding establishes the foundation for the creation of screening tests which can identify individuals susceptible to MH, thus providing potential life-saving diagnosis and treatment options for the equine population.

Cite This Article

APA
Aleman M, Riehl J, Aldridge BM, Lecouteur RA, Stott JL, Pessah IN. (2004). Association of a mutation in the ryanodine receptor 1 gene with equine malignant hyperthermia. Muscle Nerve, 30(3), 356-365. https://doi.org/10.1002/mus.20084

Publication

ISSN: 0148-639X
NlmUniqueID: 7803146
Country: United States
Language: English
Volume: 30
Issue: 3
Pages: 356-365

Researcher Affiliations

Aleman, Monica
  • Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, California 95616, USA. mraleman@ucdavis.edu
Riehl, Joyce
    Aldridge, Brian M
      Lecouteur, Richard A
        Stott, Jeffrey L
          Pessah, Isaac N

            MeSH Terms

            • Amino Acid Sequence
            • Animals
            • Base Sequence
            • Histocytochemistry
            • Horse Diseases / genetics
            • Horse Diseases / metabolism
            • Horses
            • Malignant Hyperthermia / genetics
            • Malignant Hyperthermia / metabolism
            • Malignant Hyperthermia / veterinary
            • Molecular Sequence Data
            • Muscle, Skeletal / metabolism
            • Mutation
            • Protein Binding
            • Protein Isoforms / genetics
            • Protein Isoforms / metabolism
            • Ryanodine Receptor Calcium Release Channel / genetics
            • Ryanodine Receptor Calcium Release Channel / metabolism

            Grant Funding

            • 1R01 AR46513 / NIAMS NIH HHS

            Citations

            This article has been cited 9 times.
            1. Derks MFL, Steensma M. Review: Balancing Selection for Deleterious Alleles in Livestock.. Front Genet 2021;12:761728.
              doi: 10.3389/fgene.2021.761728pubmed: 34925454google scholar: lookup
            2. Aleman M, Zhang R, Feng W, Qi L, Lopez JR, Crowe C, Dong Y, Cherednichenko G, Pessah IN. Dietary Caffeine Synergizes Adverse Peripheral and Central Responses to Anesthesia in Malignant Hyperthermia Susceptible Mice.. Mol Pharmacol 2020 Oct;98(4):351-363.
              doi: 10.1124/mol.120.119412pubmed: 32764093google scholar: lookup
            3. Lawal TA, Wires ES, Terry NL, Dowling JJ, Todd JJ. Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019.. Orphanet J Rare Dis 2020 May 7;15(1):113.
              doi: 10.1186/s13023-020-01384-xpubmed: 32381029google scholar: lookup
            4. Campion DP, Dowell FJ. Translating Pharmacogenetics and Pharmacogenomics to the Clinic: Progress in Human and Veterinary Medicine.. Front Vet Sci 2019;6:22.
              doi: 10.3389/fvets.2019.00022pubmed: 30854372google scholar: lookup
            5. Skelding A, Valverde A. Intra-operative hyperthermia in a young Angus bull with a fatal outcome.. Can Vet J 2017 Jun;58(6):614-616.
              pubmed: 28588337
            6. Jun J, Cho YS, Hu H, Kim HM, Jho S, Gadhvi P, Park KM, Lim J, Paek WK, Han K, Manica A, Edwards JS, Bhak J. Whole genome sequence and analysis of the Marwari horse breed and its genetic origin.. BMC Genomics 2014;15 Suppl 9(Suppl 9):S4.
              doi: 10.1186/1471-2164-15-S9-S4pubmed: 25521865google scholar: lookup
            7. Fernandez-Fuente M, Terracciano CM, Martin-Duque P, Brown SC, Vassaux G, Piercy RJ. Calcium homeostasis in myogenic differentiation factor 1 (MyoD)-transformed, virally-transduced, skin-derived equine myotubes.. PLoS One 2014;9(8):e105971.
              doi: 10.1371/journal.pone.0105971pubmed: 25148524google scholar: lookup
            8. Doan R, Cohen ND, Sawyer J, Ghaffari N, Johnson CD, Dindot SV. Whole-genome sequencing and genetic variant analysis of a Quarter Horse mare.. BMC Genomics 2012 Feb 17;13:78.
              doi: 10.1186/1471-2164-13-78pubmed: 22340285google scholar: lookup
            9. Giulivi C, Ross-Inta C, Omanska-Klusek A, Napoli E, Sakaguchi D, Barrientos G, Allen PD, Pessah IN. Basal bioenergetic abnormalities in skeletal muscle from ryanodine receptor malignant hyperthermia-susceptible R163C knock-in mice.. J Biol Chem 2011 Jan 7;286(1):99-113.
              doi: 10.1074/jbc.M110.153247pubmed: 20978128google scholar: lookup